DeepMed Research

MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Phase 2

Recruiting

Conditions: Preeclampsia

Interventions: Drug: Ravulizumab

First Posted Date: 2024-03-27

Last Posted Date: 2025-05-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 14

Registration Number: NCT06333652

Locations: 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States

Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis

Phase 1

Active, not recruiting

Conditions: Osteoarthritis
OA
Knee Osteoarthritis

Interventions: Biological: Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP)

First Posted Date: 2024-03-26

Last Posted Date: 2025-02-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06329492

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry

Not Applicable

Recruiting

Conditions: Dysphagia
Gastroesophageal Reflux
Esophageal Motility Disorders

Interventions: Diagnostic Test: diaphragmatic breathing

First Posted Date: 2024-03-26

Last Posted Date: 2025-04-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT06329583

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Clinical and Molecular Characteristics of Histiocytic Disorders

Recruiting

Conditions: Histiocytic Disorder

Interventions: Other: Non-Interventional Study

First Posted Date: 2024-03-26

Last Posted Date: 2025-03-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 500

Registration Number: NCT06331377

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Optimizing the Patient Experience Through Provider Coaching or Communication Intervention

Not Applicable

Active, not recruiting

Conditions: Communication
Patient Satisfaction

Interventions: Behavioral: Intervention 1

First Posted Date: 2024-03-26

Last Posted Date: 2025-03-06

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT06329557

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

Recruiting

Conditions: Prostate Carcinoma

Interventions: Other: Non-Interventional Study

First Posted Date: 2024-03-22

Last Posted Date: 2025-02-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 130

Registration Number: NCT06326216

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer

Not Applicable

Recruiting

Conditions: Localized Prostate Adenocarcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8

Interventions: Procedure: Computed Tomography
Procedure: Cone-Beam Computed Tomography
Procedure: Stereotactic Ablative Radiotherapy
Radiation: Image-Guided Adaptive Radiation Therapy
Procedure: Magnetic Resonance Imaging
Other: Survey Administration

First Posted Date: 2024-03-22

Last Posted Date: 2025-02-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 144

Registration Number: NCT06325046

Locations: 🇺🇸
Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States
🇺🇸
Mayo Clinic Health System-Mankato, Mankato, Minnesota, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

and more 2 locations

Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:

Phase 2

Recruiting

Conditions: Pharmacogenomic Drug Interaction
Side Effect of Drug
Drug Metabolism, Poor, CYP2D6-Related
Ineffective Drug Action
Drug Metabolism, Poor, CYP2C19-Related

Interventions: Diagnostic Test: PGx panel test

First Posted Date: 2024-03-21

Last Posted Date: 2024-12-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 66

Registration Number: NCT06322238

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors

Not Applicable

Recruiting

Conditions: Brain Neoplasms

Interventions: Procedure: Intracranial Catheter Placement
Procedure: Lumbar Puncture
Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography

First Posted Date: 2024-03-21

Last Posted Date: 2025-04-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 10

Registration Number: NCT06322602

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy

Not Applicable

Recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Acupressure Therapy
Other: Educational Intervention
Other: Electronic Health Record Review
Other: Questionnaire Administration

First Posted Date: 2024-03-21

Last Posted Date: 2025-03-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT06322615

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy